Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - james+hecker
Transient gene therapy for neuroprotection
Safe, minimally-invasive, non-viral delivery of nucleic acid into the central nervous system (CNS) to protect cells from ischemic or traumatic injuryProblem: Gene therapy has significant potential to advance clinical medicine. However, long-term gene expression delivered by viral modes may contribute to risks, and the duration of expression must be...
Therapeutics & Vaccines
© 2021. All Rights Reserved. Powered by